Ridgefield, Conn., U.S., and Ingelheim, Germany
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell...
VICTORIA, Seychelles, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has announced an exclusive promotion for FTX creditors effective from February ...
SES’s O3b mPOWER enhances offshore operations with high-performance connectivity to a Floating Production Storage and Offloading (FPSO) vessel
LUXEMBOURG -- (BUSINESS WIRE) --
SES announced today...
